SUPPORTIVE CARE FOR PEOPLE LIVING WITH OR BEYOND CANCER TREATMENT
Dr Hannah Wardill, Hospital Research Foundation Fellow, University of Adelaide & Head of Supportive Oncology Group (Precision Cancer Medicine)
SAHMRI (South Australian Health and Medical Research Institute)
RESEARCHER PROFILE
Filmed in Adelaide, South Australia | January 2025
Dr Hannah Wardill is a Hospital Research Foundation Fellow and lead of the Supportive Oncology Research Group (SORG), in the School of Biomedicine, University of Adelaide and Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI). She is an Executive Board Member of the Multinational Association for Supportive Care in Cancer / International Society for Oral Oncology (MASCC/ISOO) and Chair of both MASCC/ISOO Patient Partnership Committee & the Palliative Care Clinical Studies Collaborative (PaCCSC) Cancer Symptom Trials (Gut Dysfunction Node; supported by Cancer Australia).
While her research started in understanding how chemotherapy damages gut health, Dr Wardill’s research program has now expanded to include a range of symptoms and side effects including neuropathy, cognitive impairment, infection and malnutrition.
A fierce advocate for supportive cancer care, Dr Wardill is working to improve the visibility of this research area and remind people that optimal cancer control can (and should) involve high quality, evidence-based supportive care to ensure people living with or beyond cancer can live happy and fulfilling lives.
You Might also like
-
Links investigated between poor sleep and onset of dementia
Watch Samantha Bramich, a PHD candidate at the Wicking Dementia Research and Education Centre, University of Tasmania talk on identify the prevalence of rapid eye movement sleep behaviour disorder (RBD) in Tasmania and how poor sleep contributes to the onset of dementia and other diseases.
-
Dr Meghan McIlwain
DR MEGHAN MCILWAIN, CLINICAL RESEARCH MANAGER
PRESIDENT, THE NEW ZEALAND ASSOCIATION OF CLINICAL RESEARCH,
AUCKLAND, NEW ZEALAND -
Environmental exposure to function of lung epithelial stem cell biology
Dr Clare Weeden has recently commenced as a Laboratory Head at WEHI in 2025, supported by the CSL Centenary Fellowship.
Dr Weeden specialises in lung epithelial cell biology in the context of homeostasis, inflammation, and lung cancer, particularly in people who don’t smoke. Her work endeavours to understand how past environmental exposures shape the responses of lung cells and the molecular mechanisms underlying this cellular recall, with the aim to develop novel early detection strategies for lung disease.